• 简

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Corona (TSE:5909) Stock Price Looks Stretched Against Quarterly Losses

    Simply Wall St·07/31/2026 08:31:59
    语音播报

    Corona went into this earnings print priced for perfection. The stock closed at ¥999 after a flat month, even though the longer 7 day return drifted slightly lower. The headline from the quarter is a profit squeeze. Corona posted a net loss of ¥449 million with basic earnings per share of a ¥15.35 loss, even as quarterly revenue held around ¥18.9b.

    That gap between a premium valuation and loss making quarterly results is what the market now has to digest. The rest of the report explains how this tension lines up with the recent improvement in trailing 12 month earnings.

    Is Corona a quality stock temporarily caught in a profit squeeze, or is this ¥999 share price already baking in too much optimism? See whether the cash flows and multiples line up in our valuation analysis for Corona

    Q1 2027 Earnings Summary

    • Revenue Q1 2027 vs Q1 2026: ¥18,942m vs ¥18,904m (broadly unchanged over the year)
    • Net Income Q1 2027 vs Q1 2026: loss of ¥449m vs loss of ¥532m (loss narrowed by about 15.6%)
    • Basic EPS Q1 2027 vs Q1 2026: loss of ¥15.35 per share vs loss of ¥18.21 per share (per share loss narrowed by about 15.7%)
    • Trailing 12 month Net Profit Margin Q1 2027 vs prior year: 1.3% vs 0.9% (margin improved over the year)

    Prefer clear visuals instead of combing through every line of Corona's earnings release and raw figures. See Corona's full financial picture, including an easy-to-read view of its recent profitability trends, in our company report for Corona.

    TSE:5909 Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026
    TSE:5909 Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026

    Corona earnings and the cautious Bullish read

    For investors leaning positive on Corona as a steady domestic appliance business, the latest figures offer some support. Revenue in Q1 2027 held broadly flat year on year, which fits a mature, defence focused profile rather than a shrinking one. The quarterly loss narrowed compared with Q1 2026 and the trailing 12 month net profit margin improved from 0.9% to 1.3%. That direction suggests profitability has been moving up over the past year, even if this quarter still shows pressure.

    Profit squeeze keeps Bearish concerns in play

    The bear side still has material evidence to point to. Corona remains loss making this quarter, with a net loss of ¥449m and a basic loss per share of ¥15.35, despite revenue staying near ¥18.9b. This means the company is not currently converting its long standing heater and appliance franchise into consistent quarterly profit. The share price was flat over the month to 31 July 2026 and the 7 day return slipped, which hints that investors are not rewarding the recent margin improvement yet.

    After thin free cash flow cover for Corona's dividend and recent earnings pressure, review our independent risk analysis for Corona which shows 2 important warning signs

    Stay Ahead With Simply Wall St

    If Corona's mix of a profit squeeze and improving trailing 12 month margin has your attention, register free with Simply Wall St and add it to your Watchlist to track the share price against fair value and watch for a more attractive entry point. After you buy or if you already hold the stock, use the Portfolio Command Center to cut through market noise and focus on the most important updates to Corona and your other holdings. For a longer term edge, tap into the Community to see how other investors are thinking about Corona and similar stocks. By spotting potential catalysts and risks early, you can make quicker, more confident decisions and stay informed about market developments.

    Seeking Alternatives Beyond Corona Stock

    Fresh stock ideas move quickly. Breakout stories can gather momentum while others start dropping back toward fair value. Scan what is still under the radar for now and get in early.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.